PHARMACOLOGICAL TREATMENT OF IMMUNE-MEDIATED INNER-EAR DISORDERS - A CLINICAL IMMUNOLOGY AND AUDIOLOGY SURVEY

被引:0
作者
VELDMAN, JE
机构
来源
SCANDINAVIAN AUDIOLOGY | 1986年
关键词
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
[21]   Intratympanic gadolinium magnetic resonance imaging supports the role of endolymphatic hydrops in the pathogenesis of immune-mediated inner-ear disease [J].
Lobo, D. ;
Tunon, M. ;
Villarreal, I. ;
Brea, B. ;
Garcia-Berrocal, J. R. .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2018, 132 (06) :554-559
[22]   Immune-mediated inner ear disease: 10-year experience [J].
Broughton, SS ;
Meyerhoff, WE ;
Cohen, SB .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 34 (02) :544-548
[23]   Review of the biologic agents used for immune-mediated inner ear disease [J].
Lobo, David ;
Garcia-Berrocal, Jose R. ;
Trinidad, Almudena ;
Verdaguer, Jose M. ;
Ramirez-Camacho, Rafael .
ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2013, 64 (03) :223-229
[24]   Spectrum of immune-mediated inner ear disease and cochlear implant results [J].
Malik, Mohammad U. ;
Pandian, Vinciya ;
Masood, Hamid ;
Diaz, David A. ;
Varela, Voss ;
Davalos-Balderas, Alfredo Jose ;
Parra-Cardenas, Martha ;
Seo, Phillip ;
Francis, Howard W. .
LARYNGOSCOPE, 2012, 122 (11) :2557-2562
[25]   Cochlear Implantation Outcomes in Patients With Autoimmune and Immune-Mediated Inner Ear Disease [J].
Aftab, Saba ;
Semaan, Maroun T. ;
Murray, Gail S. ;
Megerian, Cliff A. .
OTOLOGY & NEUROTOLOGY, 2010, 31 (08) :1337-1342
[26]   Immune-mediated Movement Disorders: clinical manifestations, treatment, and evolution: A multicenter study [J].
Bala, M. ;
Gonzalez, F. ;
Saucedo, M. ;
Bandeo, L. ;
Chertcoff, A. ;
De Francesco, L. ;
Napoli, G. ;
Leon Cejas, L. ;
Bonardo, P. ;
Morera, N. ;
Tschopp, L. ;
Rugilo, C. ;
Calandra, C. ;
Pellene, A. ;
Raina, G. ;
Salazar, Z. ;
Rinaldi, G. ;
Judewicz, P. ;
Rivas, J. ;
Gustavo Jose, J. ;
Ballesteros, D. ;
Tela, M. ;
Gualtieri, F. ;
Amor, J. ;
Esliman, C. ;
Caiza Zambrano, F. ;
Arakaki, T. ;
Garretto, N. ;
Rodriguez, S. ;
Kohler, A. ;
Laffue, A. ;
Martinez, O. ;
Fernandez Pardal, M. ;
Reisin, R. ;
Uribe Roca, C. .
MOVEMENT DISORDERS, 2021, 36 :S137-S138
[27]   Use of IGIV in the treatment of immune-mediated dermatologic disorders [J].
Gelfand, EW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (01) :92-96
[28]   Principles and approaches to the treatment of immune-mediated movement disorders [J].
Mohammad, Shekeeb S. ;
Dale, Russell C. .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2018, 22 (02) :292-300
[29]   THE ROLE OF THERAPEUTIC APHERESIS IN THE TREATMENT OF IMMUNE-MEDIATED DISORDERS [J].
Rafajlovski, A. ;
Ostojic, G. ;
Todorovic, M. ;
Balint, B. ;
Jevtic, M. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 :683-683
[30]   New treatment options for immune-mediated hematological disorders [J].
Dierickx, Daan ;
De Rycke, Anja ;
Vanderschueren, Steven ;
Delannoy, Andre .
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (08) :579-586